Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alain Lozniewski is active.

Publication


Featured researches published by Alain Lozniewski.


Journal of Clinical Microbiology | 2001

Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.

Alain Lozniewski; C. Rabaud; Emmanuelle Dotto; M. Weber; Francine Mory

ABSTRACT Detection of Clostridium difficile toxins A and B in stools by Premier Cytoclone A+B enzyme immunoassay (EIA) was compared with detection by stool culture for C. difficile followed by detection of toxigenic isolates using the same EIA. Chart reviews were performed to evaluate the likelihood of C. difficile-associated diarrhea and colitis (CADC) for all patients with at least one positive toxin assay. While the toxins were detected in 58 of 85 consecutive CADC patients by both assays, CADC in 5 patients was detected only by stool toxin assay, and in 22 patients CADC was detected only by toxigenic culture. Our results suggest that for laboratories using a rapid toxin A+B EIA, direct toxin detection in stools should be combined with toxigenic culture in cases in which there is a negative stool toxin assay.


Antimicrobial Agents and Chemotherapy | 2003

Efficacy of Sulforaphane in Eradicating Helicobacter pylori in Human Gastric Xenografts Implanted in Nude Mice

Xavier Haristoy; Karine Angioi-Duprez; Adrien Duprez; Alain Lozniewski

ABSTRACT Sulforaphane, an isothiocyanate abundant in the form of its glucosinolate precursor in broccoli sprouts, has shown in vitro activity against Helicobacter pylori. We evaluated the effect of sulforaphane in vivo against this bacterium by using human gastric xenografts in nude mice. H. pylori was completely eradicated in 8 of the 11 sulforaphane-treated grafts. This result suggests that sulforaphane might be beneficial in the treatment of H. pylori-infected individuals.


Critical Care Medicine | 2008

Effects of the Trem-1 pathway modulation during mesenteric ischemia-reperfusion in rats

Sébastien Gibot; Frédéric Massin; Corentine Alauzet; Chantal Montemont; Alain Lozniewski; Pierre-Edouard Bollaert; Bruno Levy

Objectives: The triggering receptor expressed on myeloid cells (TREM)-1, a receptor expressed on the surface of neutrophils and monocytes/macrophages, synergizes with the Toll-like receptors in amplifying the inflammatory response mediated by microbial components. Because the pathogenesis of ischemia-reperfusion-induced gastrointestinal tissue injury and multiple organ failure implies leukocyte activation and bacterial translocation, we hypothesized that the TREM-1 pathway modulation would prove beneficial in this setting. Design: Animal study. Setting: Research laboratory. Subjects: Adult male Wistar rats (250–300 g). Interventions: Rats were subjected to intestinal ischemia-reperfusion induced by occlusion of the superior mesenteric artery during 60 mins and reperfused for 180 mins. At the time of reperfusion, animals were administered with LP17 (a synthetic TREM-1 inhibitor), a control peptide, or a vehicle (normal saline). Plasma concentrations of tumor necrosis factor-&agr;, interleukin-6, and soluble TREM-1 were measured by enzyme-linked immunosorbent assay. Hepatic activation of the transcriptional factor nuclear factor-&kgr;B was assessed by electrophoretic mobility shift assay. Hepatic oxidant-antioxidant balance was estimated by measurement of lipid peroxidation and catalase activity. Ileal mucosal permeability was estimated by fluorescein dextran-4 clearance and bacterial translocation by mesenteric lymph nodes culture. Measurements and Main Results: Ischemia-reperfusion was associated with cardiovascular collapse, lactic acidosis, and systemic and hepatic inflammatory response that were partly prevented by LP17 administration. Liver lipid peroxidation and catalase depletion were attenuated by LP17. Ischemia-reperfusion induced a marked increase in ileal mucosal permeability and an associated bacterial translocation that was also prevented by TREM-1 modulation. LP17 delayed mortality. Conclusions: The modulation of the TREM-1 pathway by the means of a synthetic peptide may be useful during acute mesenteric ischemia.


Future Microbiology | 2010

New insights into Prevotella diversity and medical microbiology

Corentine Alauzet; Hélène Marchandin; Alain Lozniewski

In light of recent studies based on cultivation-independent methods, it appears that the diversity of Prevotella in human microbiota is greater than was previously assumed from cultivation-based studies, and that the implication of these bacteria in several human diseases was unrecognized. While some Prevotella taxa were found during opportunistic infections, changes in Prevotella abundance and diversity were discovered during dysbiosis-associated diseases. As member of the microbiota, Prevotella may also be considered as a reservoir for resistance genes. Greater knowledge on Prevotella diversity, as well as new insights into its pathogenic potential and implication in dysbiosis are expected from the use of human microbe identification microarrays, from whole-genome sequence analyse, and from the NIH Human Microbiome Project data. New approaches, including molecular-based methods, could contribute to improve the diagnosis of Prevotella infections.


Antimicrobial Agents and Chemotherapy | 2010

Metronidazole Resistance in Prevotella spp. and Description of a New nim Gene in Prevotella baroniae

Corentine Alauzet; F. Mory; C. Teyssier; H. Hallage; J. P. Carlier; G. Grollier; Alain Lozniewski

ABSTRACT Nonduplicate clinical isolates of Prevotella spp. recovered from patients hospitalized between 2003 and 2006 in two French tertiary-care teaching hospitals were investigated for their susceptibility to metronidazole and the presence of nim genes. Of the 188 strains tested, 3 isolates displayed reduced susceptibility to metronidazole after 48 h of incubation, while 27 additional isolates exhibited heterogeneous resistance after prolonged incubation; all 30 of the isolates were nim negative. Among the remaining 158 isolates, 7 nim-positive isolates were detected. All of these strains were identified as Prevotella baroniae by 16S rRNA gene sequence analysis and contained a new nim gene, named nimI, as determined by DNA sequence analysis. Chromosomal localization of this single-copy gene was demonstrated in all clinical isolates as well as in type strain P. baroniae DSM 16972 by using Southern hybridization. No known associated insertion sequence elements were detected upstream of the nimI gene in any of the nim-positive strains by PCR mapping. After prolonged exposure to metronidazole, stable resistant subpopulations could be selected in nimI-positive Prevotella isolates (n = 6) as well as in nim-negative Prevotella isolates (n = 6), irrespective of their initial susceptibility to this antibiotic. This study is the first description of a new nitroimidazole resistance gene in P. baroniae which seems to be silent and which might be intrinsic in this species. Moreover, our findings highlight the fact that high-level resistance to metronidazole may be easily induced in both nim-positive and nim-negative Prevotella sp. strains.


Journal of Clinical Microbiology | 2010

Gluconobacter as Well as Asaia Species, Newly Emerging Opportunistic Human Pathogens among Acetic Acid Bacteria

Corentine Alauzet; Corinne Teyssier; Estelle Jumas-Bilak; Anne Gouby; R. Chiron; Christian Rabaud; François Counil; Alain Lozniewski; Hélène Marchandin

ABSTRACT Acetic acid bacteria (AAB) are broadly used in industrial food processing. Among them, members of the genera Asaia, Acetobacter, and Granulibacter were recently reported to be human opportunistic pathogens. We isolated AAB from clinical samples from three patients and describe here the clinical and bacteriological features of these cases. We report for the first time (i) the isolation of a Gluconobacter sp. from human clinical samples; (ii) the successive isolation of different AAB, i.e., an Asaia sp. and two unrelated Gluconobacter spp., from a cystic fibrosis patient; and (iii) persistent colonization of the respiratory tract by a Gluconobacter sp. in this patient. We reviewed the main clinical features associated with AAB isolation identified in the 10 documented reports currently available in the literature. Albeit rare, infections as well as colonization with AAB are increasingly reported in patients with underlying chronic diseases and/or indwelling devices. Clinicians as well as medical microbiologists should be aware of these unusual opportunistic pathogens, which are difficult to detect during standard medical microbiological investigations and which are multiresistant to antimicrobial agents. Molecular methods are required for identification of genera of AAB, but the results may remain inconclusive for identification to the species level.


Systematic and Applied Microbiology | 2014

Multilocus analysis reveals diversity in the genus Tissierella: Description of Tissierella carlieri sp. nov. in the new class Tissierellia classis nov.☆

Corentine Alauzet; Hélène Marchandin; Pascal Courtin; Francine Mory; Ludovic Lemée; Jean-Louis Pons; Marie-Pierre Chapot-Chartier; Alain Lozniewski; Estelle Jumas-Bilak

The genus Tissierella and its relatives Tepidimicrobium, Soehngenia and Sporanaerobacter comprise anaerobic Gram-positive bacilli classified along with Gram-positive cocci in a family with controversial placement designated as incertae sedis XI, in the phylum Firmicutes. We performed a top-down reappraisal of the taxonomy from the phylum to the species level within the genus Tissierella. Reconstruction of high-rank 16S rRNA gene-based phylogenies and their interpretation in a taxonomic purpose allowed defining Tissierellia classis nov. within the phylum Firmicutes while the frames of Tissierellales ord. nov. and Tissierellaceae fam. nov. have to be further strengthened. For species delineation in the genus Tissierella, we studied a population of clinical strains. Beside Tissierella praeacuta, a sub-population of five strains formed a clade in multilocus phylogenies (16S rRNA, cpn60, tpi, recA and spo0A genes). Data such as 16S rRNA gene similarity level, population structure, chromosome organization and murein type indicated that this clade corresponded to a novel species for which the name Tissierella carlieri sp. nov. is proposed, with type strain LBN 295(T)=AIP 268.01(T)=DSM 23816(T)=CCUG 60010(T). Such an approach, associating a phylogenetic reappraisal of high-level taxonomic ranks with weak taxonomic structure and a population study for genus and species delineation is needed to strengthen the taxonomic frame of incertae sedis groups in the phylum Firmicutes.


Journal of Antimicrobial Chemotherapy | 2013

Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA

Marine Desroches; Julien Potier; Frédéric Laurent; Anne-Sophie Bourrel; Florence Doucet-Populaire; Jean-Winoc Decousser; M. Archambaud; G. Aubert; M. Biendo; G. Blanchard-Marche; R. Bonnet; F. Robin; Nadège Bourgeois-Nicolaos; L. Bret; Jocelyne Caillon; F. Caron; C. Cattoen; E. Chachaty; H. Courtade; C. Eloy; Jerome Etienne; François Vandenesch; A. Fiacre; F. Girard-Pipau; C. Buisson-Touati; Hélène Jean-Pierre; François Jehl; Roland Leclercq; Vincent Cattoir; Jean-Philippe Lavigne

OBJECTIVES Mupirocin is the cornerstone of decolonization regimens, a successful strategy to prevent healthcare-associated staphylococcal infections. Several recent studies have reported alarming results: (i) an extending reservoir of mupA, the ancestral mobile resistance gene, among coagulase-negative staphylococci (CoNS); (ii) the emergence of a new resistance gene (mupB); and (iii) a growing number of mupirocin-resistant methicillin-resistant Staphylococcus aureus (MRSA), including highly pathogenic clones. We performed a nationwide prospective study in France to detect such trends among invasive staphylococci. METHODS Between October 2011 and February 2012, 367 MRSA and 708 CoNS invasive isolates were collected from 37 hospitals and analysed centrally. Mupirocin MICs were determined using the broth microdilution method. mupA/B PCR was performed for resistant isolates (MIC >1 mg/L). Genetic relatedness between mupirocin-resistant MRSA isolates was determined by PFGE analysis and related isolates were tested by microarray. RESULTS Among MRSA isolates 2.2% (n = 8) were classified as mupirocin resistant; 1.4% (n = 5) showing low-level resistance (MIC ≤256 mg/L) and 0.8% (n = 3) high-level resistance (MIC >256 mg/L). Only the latter isolates carried mupA. A clonal relationship was identified between two mupA-negative MRSA from the same hospital and three mupA-positive MRSA from three distant towns; these three isolates belonged to the Lyon clone. Mupirocin resistance was identified in 10.3% of CoNS, mainly highly resistant mupA-positive isolates (5.6%). The mupB gene was not detected in mupirocin-resistant MRSA or CoNS. CONCLUSIONS This first large national study indicates the need for thorough epidemiological monitoring and a stewardship programme to prevent and detect mupirocin resistance in staphylococci.


Clinical Infectious Diseases | 1999

Lung Abscess Due to β-Lactamase-Producing Pasteurella multocida

Christine Lion; Alain Lozniewski; Vincent Rosner; M. Weber

Pasteurella multocida is a commensal of the upper respiratory tract of various animals. The spectrum of human diseases caused by P. multocida varies from soft-tissue infections fol- lowing bites and scratches to systemic infections, including res- piratory tract infections resulting from airborne contamination and/or chronic carriage. Antimicrobial resistance of Pasteurella strains originating from animals has been reported for many years. Human P. multocida isolates are usually susceptible to penicillins. We report a case in which a strain of b-lacta- mase-producing P. multocida was isolated from a lung abscess specimen and review related cases. A 75-year-old woman with chronic bronchitis was hospital- ized with fever (temperature, 407C), weight loss, increased pro- ductive cough, and dyspnea. A chest x-ray was unremarkable, whereas the WBC count was 13,900/mm 3 (89% neutrophils) and the one-hour erythrocyte sedimentation rate was 63 mm/h. The patient was treated for 8 days with intravenous amoxicillin (1.5 g/d). Because of persistent signs of infection, a new chest ra- diograph was obtained, which showed a left lung abscess; the abscess was confirmed by CT. Culture of specimens obtained by bronchoalveolar lavage yielded P. multocida subspecies mul- tocida (10 5 cfu/mL) and Haemophilus parainfluenzae (10 3 cfu/ mL). Production of b-lactamase by both isolates was detected by a chromogenic test using nitrocefin-impregnated disk and the synergic effect between clavulanate and amoxicillin by disk dif- fusion testing. Minimum inhibitory concentrations of amoxi- cillin and amoxicillin/clavulanate for the P. multocida strain were of 8 and 0.25 mg/mL, respectively. Consequently, amoxi- cillin was changed to intravenous amoxicillin/clavulanic acid (3 g/d). A favorable outcome was achieved, and the patient was discharged from the hospital; medication at the time of dis- charge was oral amoxicillin/clavulanic acid for 2 months. Our patient had no known exposure to animals other than her cat. Two different strains of P. multocida (subspecies multocida and septica) were isolated from the cats saliva, but none of them was found to produce b-lactamase. A MEDLINE search of the literature revealed only 4 well- documented cases of human infections due to penicillin-resis- tant P. multocida (1-4). All 4 cases were respiratory tract in- fections. The principal features of these cases along with our case are presented in table 1. The respiratory tract is the most common site of pasteurella infections after soft tissues (5). Pre- vious studies have shown that impaired pulmonary defenses,


Shock | 2013

Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs.

Marc Derive; Amir Boufenzer; Youcef Bouazza; Frederique Groubatch; Corentine Alauzet; Damien Barraud; Alain Lozniewski; Pierre Leroy; Nguyen Tran; Sébastien Gibot

ABSTRACT The objective of this study was to determine the effects of a TREM (triggering receptor expressed on myeloid cells 1)–like transcript 1–derived peptide (LR12) administration during septic shock in pigs. Two hours after induction of a fecal peritonitis, anesthetized and mechanically ventilated adult male minipigs were randomized to receive LR12 (n = 6) or its vehicle alone (normal saline, n = 5). Two animals were operated and instrumented without the induction of peritonitis and served as controls (sham). Resuscitation was achieved using hydroxyethyl starch (up to 20 mL/kg) and norepinephrine infusion (up to 10 &mgr;g/kg per minute). Hemodynamic parameters were continuously recorded. Gas exchange, acid-base status, organ function, and plasma cytokines concentrations were evaluated at regular intervals until 24 h after the onset of peritonitis when animals were killed under anesthesia. Peritonitis induced profound hypotension, myocardial dysfunction, lactic acidosis, coagulation abnormalities, and multiple organ failure. These disorders were largely attenuated by LR12. In particular, cardiovascular failure was dampened as attested by a better mean arterial pressure, cardiac index, cardiac power index, and SvO2, despite lower norepinephrine requirements. LR12, a TREM-like transcript 1–derived peptide, exhibits salutary properties during septic shock in adult minipigs.

Collaboration


Dive into the Alain Lozniewski's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Weber

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xavier Haristoy

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge